I. Mokrousov (St. Petersburg, Russian Federation), C. Prat Aymerich (Badalona (Barcelona), Spain)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Associations between lipid mediators and cytokine production at different stages of MTB infection
Y. Todorova (Sofia, Bulgaria), R. Emilova (Sofia, Bulgaria), V. Milanov (Sofia, Bulgaria), E. Bachiyska (Sofia, Bulgaria), Y. Atanasova (Sofia, Bulgaria), A. Baykova (Sofia, Bulgaria), M. Nikolova (Sofia, Bulgaria)
|   |
Cardiotoxicity of a complex of anti-tuberculosis drugs with the inclusion of fluoroquinolones and bedaquiline in an experiment on rats
G. Mozhokina (Moscow, Russian Federation), U. Zuzya (Moscow, Russian Federation)
| |
Mycobacterial small noncoding RNAs MTS0997 and MTS1338 are novel virulence factors of M. tuberculosis.
G. Shepelkova (Moscow, Russian Federation), V. Evstifeev (Moscow, Russian Federation), I. Sivokozov (Moscow, Russian Federation), T. Azhikina (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation)
| |
Inflammation regulating cytokines in TB affected tissues.
G. Shepelkova (Moscow, Russian Federation), V. Evstifeev (Moscow, Russian Federation), R. Tarasov (Moscow, Russian Federation), M. Bagirov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation)
| |
Expression of MDR1 gene encoding P-glycoprotein is significantly increased in active pulmonary tuberculomas
M. Erokhina (Moscow, Russian Federation), L. Lepekha (Moscow, Russian Federation), E. Rybalkina (Moscow, Russian Federation), E. Pavlova (Moscow, Russian Federation), R. Tarasov (Moscow, Russian Federation), E. Krasnikova (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
| |
CELL DEATH MODES OF WHITE BLOOD CELLS IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA AND PULMONARY TUBERCULOSIS
O. Hovardovska (Kharkiv, Ukraine), O. Schevchenko (Kharkiv, Ukraine), O. Nakonechna (Kharkiv, Ukraine), Y. Kalashnyk-Vakulenko (Kharkiv, Ukraine), A. Tkachenko (Kharkiv, Ukraine), A. Onishchenko (Kharkiv, Ukraine), Y. Manchenko (Kharkiv, Ukraine)
| |
Indoleamine 2,3-dioxygenase 1 (IDO1) activity arrests the apoptosis of Mycobacterium tuberculosis (M. tuberculosis)-infected macrophages
L. Guo (Amsterdam, Netherlands), B. Hollestelle (Amsterdam, Netherlands), S. A.M. Tromp (Amsterdam, Netherlands), A. Dijkhuis (Amsterdam, Netherlands), R. Lutter (Amsterdam, Netherlands)
| |
The gut microbiota state in patients with pulmonary tuberculosis.
V. Shorokhova (Moscow, Russian Federation), R. Abdullaev (Moscow, Russian Federation), O. Komissarova (Moscow, Russian Federation)
| |
Antimycobacterial signaling pathways are differentially regulated in alveolar macrophages of tuberculosis patients
E. Ufimtseva (Novosibirsk, Russian Federation), N. Eremeeva (Yekaterinburg, Russian Federation), D. Vakhrusheva (Yekaterinburg, Russian Federation), S. Skornyakov (Yekaterinburg, Russian Federation)
| |
Characteristic of M.tuberculosis in the Central Region of the Russian Federation (2017-2019)
S. Andreevskaya (Moscow, Russian Federation), T. Smirnova (Moscow, Russian Federation), L. Chernousova (Moscow, Russian Federation), E. Larionova (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
| |
The Beijing genotype dominates the multidrug-resistant Mycobacterium tuberculosis population in North-West Russia
A. Vyazovaya (St. Petersburg, Russian Federation), A. Gerasimova (St. Petersburg, Russian Federation), N. Solovieva (St. Petersburg, Russian Federation), D. Starkova (St. Petersburg, Russian Federation), N. Vasilieva (St. Petersburg, Russian Federation), D. Terentieva (St. Petersburg, Russian Federation), R. Mudarisova (St. Petersburg, Russian Federation), V. Zhuravlev (St. Petersburg, Russian Federation), O. Narvskaya (St. Petersburg, Russian Federation)
| |
Electronic antibiograms of Mycobacterium tuberculosis using Illumina whole genome sequencers data and Mykrobe software tool predictor.
V. Tolchkov (Sofia, Bulgaria)
| |
Highly lethal strain cluster of the Mycobacterium tuberculosis Beijing genotype endemically prevalent in Buryatia, Russia
I. Mokrousov (St. Petersburg, Russian Federation), T. Vinogradova (St. Petersburg, Russian Federation), M. Dogonadze (St. Petersburg, Russian Federation), M. Badleeva (Ulan-Ude, Russian Federation), I. Yarusova (Omsk, Russian Federation), N. Zabolotnykh (St. Petersburg, Russian Federation), M. Vitovskaya (St. Petersburg, Russian Federation), A. Vyazovaya (St. Petersburg, Russian Federation), A. Gerasimova (St. Petersburg, Russian Federation), S. Zhdanova (Irkutsk, Russian Federation), P. Khromova (Irkutsk, Russian Federation), V. Sinkov (Irkutsk, Russian Federation), V. Molchanov (St. Petersburg, Russian Federation), E. Chernyaeva (St. Petersburg, Russian Federation), N. Solovieva (St. Petersburg, Russian Federation), O. Pasechnik (Omsk, Russian Federation), O. Ogarkov (Irkutsk, Russian Federation)
| |
Determination of the six polymorphisms in the NAT2 gene helps to predict isoniazid side effects.
K. Galkina (Moscow, Russian Federation), M. Sviridenko (Moscow, Russian Federation), E. Nosova (Moscow, Russian Federation), A. Khakhalina (Moscow, Russian Federation), A. Isakova (Moscow, Russian Federation), S. Safonova (Moscow, Russian Federation)
| |
Changes in the metabolism of Mycobacterium tuberculosis during the course of TB treatment
J. Bespyatykh (Moscow, Russian Federation)
| |
Late Breaking Abstract - Transcriptomic signature for precise prediction of systemic drug reaction during 3HP treatment for latent tuberculosis infection
J. Wang (Taipei, Taiwan), H. Huang (Kaohsiung, Taiwan), J. Yang (Hsinchu, Taiwan), I. Chong (Kaohsiung, Taiwan)
| |
Late Breaking Abstract - Clinical and epidemiological characteristics of Co-infection: respiratory tuberculosis and COVID-19.
E. Klester (Barnaul (Altai Region), Russian Federation), K. Klester (Barnaul (Altai Region), Russian Federation), M. Shchigaleva (Barnaul (Altai Region), Russian Federation), P. Lyashko (Barnaul (Altai Region), Russian Federation), L. Hachatryan (Barnaul (Altai Region), Russian Federation)
| |
Late Breaking Abstract - Bedaquiline enhances receptor phagocytosis and decreases IL1b production in human pro-inflammatory macrophages
E. Pavlova (Moscow, Russian Federation), M. Erokhina (Moscow, Russian Federation)
| |